CollTech raises $1.1m

By Helen Schuller
Tuesday, 16 August, 2005

Western Australian collagen purification company CollTech (ASX:CAU) has raised AUD$1.1 million by way of a private placement to institutional and professional investors.

The capital raising was managed by BBY Limited via placement of fully paid ordinary shares at 9.5 cents per share and represents an 11.7 per cent discount to CollTech's weighted volume average price in the 5 days prior to August 8.

CEO Michael Pixley said the money would be used for marketing in Europe and North America. CollTech has developed and patented a manufacturing technology enabling the commercial extraction of collagen from ovine (sheep) skins, which it claims has higher yields and purity than that extracted from traditional bovine and porcine sources.

CollTech has also launched a share purchase plan, after which it expects to have $3.2 million in the bank.

Related News

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd